Adagio Medical (ADGM) Stock Analysis

What Adagio Medical does

Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.

Key metrics

ETFs linked to ADGM

Broad-market and Healthcare sector ETFs an investor holding Adagio Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ADGM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Adagio Medical?

Adagio Medical trades under the ticker ADGM on NASDAQ.

Which exchange is ADGM listed on?

ADGM is listed on NASDAQ.

What sector does Adagio Medical operate in?

Adagio Medical is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze ADGM in a portfolio?

PortView shows ADGM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.